These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8980753)

  • 61. Efficacy of ciprofloxacin in experimental arthritis caused by Escherichia coli--in vitro-in vivo correlations.
    Bayer AS; Norman D; Anderson D
    J Infect Dis; 1985 Oct; 152(4):811-6. PubMed ID: 2931489
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Penetration of parenterally administered gentamicin into the cerebrospinal fluid in experimental meningitis.
    Goitein K; Michel J; Sacks T
    Chemotherapy; 1975; 21(3-4):181-8. PubMed ID: 1157573
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits.
    Täuber MG; Shibl AM; Hackbarth CJ; Larrick JW; Sande MA
    J Infect Dis; 1987 Sep; 156(3):456-62. PubMed ID: 3302052
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience.
    Wie SH; Kim HW; Chang UI
    Microb Drug Resist; 2013 Aug; 19(4):316-22. PubMed ID: 23473263
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Once-daily versus multiple-daily gentamicin in empirical antibiotic therapy of febrile neutropenia following intensive chemotherapy.
    Bakri FE; Pallett A; Smith AG; Duncombe AS
    J Antimicrob Chemother; 2000 Mar; 45(3):383-6. PubMed ID: 10702563
    [TBL] [Abstract][Full Text] [Related]  

  • 66. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.
    Rao SC; Ahmed M; Hagan R
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005091. PubMed ID: 16437518
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.
    Prins JM; Weverling GJ; de Blok K; van Ketel RJ; Speelman P
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2494-9. PubMed ID: 8913452
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Kanamycin and gentamicin treatment of neonatal sepsis and meningitis.
    Chang MJ; Escobedo M; Anderson DC; Hillman L; Feigin RD
    Pediatrics; 1975 Nov; 56(5):695-9. PubMed ID: 1105375
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacokinetics and bacteriological efficacy of mezlocillin in experimental Escherichia coli and Listeria monocytogenes meningitis.
    Odio C; Thomas ML; McCracken GH
    Antimicrob Agents Chemother; 1984 Apr; 25(4):427-32. PubMed ID: 6375552
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of amikacin dosing regimens in neutropenic guinea pigs with Escherichia coli infection.
    McClure JT; Rosin E
    Am J Vet Res; 1998 Jun; 59(6):750-5. PubMed ID: 9622746
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gentamicin in neonatal infection: once versus twice daily dosage.
    Chotigeat U; Narongsanti A; Ayudhya DP
    J Med Assoc Thai; 2001 Aug; 84(8):1109-15. PubMed ID: 11758844
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Susceptibility of Escherichia coli K1 to four combinations of antimicrobial agents potentially useful for treatment of neonatal meningitis.
    Paisley JW; Washington JA
    J Infect Dis; 1979 Aug; 140(2):183-91. PubMed ID: 383854
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combined intrathecal and intramuscular gentamicin for gram-negative meningitis. Pharmacologic study of 21 patients.
    Rahal JJ; Hyams PJ; Simberkoff MS; Rubinstein E
    N Engl J Med; 1974 Jun; 290(25):1394-8. PubMed ID: 4208369
    [No Abstract]   [Full Text] [Related]  

  • 74. [Tolerability of once-daily-dosing of intravenous gentamicin in preterm neonates born at 32-37 weeks of gestation].
    Miron D; Steinfeld M; Hasanein J; Felszer C; Reich D
    Harefuah; 2003 Jun; 142(6):413-5, 487. PubMed ID: 12858823
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Lutsar I; Ahmed A; Friedland IR; Trujillo M; Wubbel L; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2414-7. PubMed ID: 9371342
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical conferences at the Johns Hopkins Hospital. Gram-negative bacillary meningitis.
    Johns Hopkins Med J; 1978 Aug; 143(2):60-3. PubMed ID: 355698
    [No Abstract]   [Full Text] [Related]  

  • 77. Easier monitoring of aminoglycoside therapy with once-daily dosing schedules.
    Prins JM; Koopmans RP; Büller HR; Kuijper EJ; Speelman P
    Eur J Clin Microbiol Infect Dis; 1995 Jun; 14(6):531-5. PubMed ID: 7588829
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa.
    Tam VH; Kabbara S; Vo G; Schilling AN; Coyle EA
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2626-31. PubMed ID: 16870751
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparative pharmacokinetics of once daily intravenous and intramuscular gentamicin in patients with post partum endometritis.
    Gemer O; Harari D; Mishal J; Segal S
    Arch Gynecol Obstet; 2001 Mar; 265(1):34-5. PubMed ID: 11327091
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of meropenem in experimental meningitis.
    Nairn K; Shepherd GL; Edwards JR
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():73-84. PubMed ID: 8543501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.